Follow
Boris Vabson
Boris Vabson
Verified email at hcp.med.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Who benefits when the government pays more? Pass-through in the Medicare Advantage program
M Duggan, A Starc, B Vabson
Journal of Public Economics 141, 50-67, 2016
1662016
The consequences of health care privatization: evidence from Medicare Advantage exits
M Duggan, J Gruber, B Vabson
American Economic Journal: Economic Policy 10 (1), 153-186, 2018
88*2018
Health care rationing in public insurance programs: Evidence from Medicaid
TJ Layton, N Maestas, D Prinz, B Vabson
American Economic Journal: Economic Policy 14 (4), 397-431, 2022
37*2022
Rationing medicine through bureaucracy: authorization restrictions in medicare
ZC Brot-Goldberg, S Burn, T Layton, B Vabson
National Bureau of Economic Research, 2023
332023
The behavioral foundations of default effects: theory and evidence from Medicare Part D
Z Brot-Goldberg, T Layton, B Vabson, AY Wang
American Economic Review 113 (10), 2718-2758, 2023
282023
Comparison of care quality metrics in 2-sided risk Medicare Advantage vs fee-for-service Medicare programs
K Cohen, O Ameli, CE Chaisson, K Catlett, J Chiang, A Kwong, ...
JAMA network open 5 (12), e2246064-e2246064, 2022
72022
Efficiency Gains Under Incomplete Contracting: Evidence from Medicaid
B Vabson
Stanford Institute for Economic Policy Research Job Market Paper, 2017
62017
How Should Policymakers Respond To Growth In Cost Sharing That Often Goes Unpaid?
B Ippolito, B Vabson
Health Affairs Forefront, 2023
32023
Rationing Medicine Through Paperwork: Authorization Restrictions in Medicare
Z Brot-Goldberg, T Layton, S Burn, B Vabson
2021 APPAM Fall Research Conference, 2022
22022
Predicting disability enrollment using machine learning
T Layton, H Liebert, N Maestas, D Prinz, B Vabson
NBER Working Paper No. NB18-Q4). National Bureau of Economic Research …, 2019
22019
Essays in health economics and public finance
BV Vabson
University of Pennsylvania, 2015
22015
How Do Prescription Drug Benefits Differ Between Medicare Advantage and Stand-Alone Part D Drug Plans?
BN Ippolito, B Vabson
< bound method Organization. get_name_with_acronym of< Organization …, 2024
2024
Medicaid vs Medicare: Evidence from Medicaid to Medicare Transitions at 65
T Layton, N Maestas, D Prinz, M Shepard, B Vabson
2024
The value of improving insurance quality: Evidence from long-run Medicaid attrition
A Lee, B Vabson
Journal of Health Economics 94, 102865, 2024
2024
Quality Outcomes Under Medicare Advantage vs. Medicare Fee-for-Service
B Vabson, C Teigland, Z Pulungan, Y Su, Z Brot-Goldberg, S Bilder, ...
AEI: American Enterprise Institute for Public Policy Research, 2024
2024
Harvard-Inovalon Medicare Study: Utilization and Efficiency Under Medicare Advantage vs. Medicare Fee-for-Service
B Vabson, S Bilder, ZC Brot-Goldberg, BT Jones, I Mohammadi, ...
AEI: American Enterprise Institute for Public Policy Research, 2023
2023
The Value of Improving Insurance Quality: Evidence from Long-Run Medicaid Attrition
B Vabson, A Lee
AEI: American Enterprise Institute for Public Policy Research, 2023
2023
Estimating Variation in Productivity Across State Medicaid Programs: Evidence from Dual-Eligibles
T Layton, N Maestas, D Prinz, M Shepard, B Vabson
2023
Rationing Medicine Through Bureaucracy: Authorization Restrictions in Medicare
B Vabson, Z Brot-Goldberg, S Burn, T Layton
AEI: American Enterprise Institute for Public Policy Research, 2023
2023
HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare …
C Teigland, Z Pulungan, I Mohammadi, BT Jones, S Bilder, ...
Value in Health 26 (6), S215, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20